Representative domains include: Gastrointestinal and hepatic models: Protection against ulcers, leaky gut, IBSlike symptoms, Crohntype inflammation, and toxic liver injury (e.g., CCl4, NSAID, and alcohol models), with improved mucosal healing and barrier integrity
Inject in one quadrant per day, moving to the next quadrant the following day
Patent 6,268,343
The primary antibodies were anti-GPX1 (1:1,000 dilution, GeneTex, GTX116040), anti-C-caspase 3 (1:500 dilution, Cell Signaling Technology, 9664), anti-4-HNE (1:1000, Abcam, ab46545), anti-phosphorylated (p)-NFB p65 (1:1,000 dilution, Cell Signaling Technology, 3033), and anti--actin (1:2,000 dilution, ZSGB-BIO, TA-09)
I tried a 2nd charger and all good, I could see it was drawing about 400mA (I had the charger switches set for 500mA mode)
J Chin Med Assoc